Publikationsliste
Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia.
Schmidt S, Gastl G, Wolf D.
Leuk Lymphoma 1 Apr 2008; 49(4)643-7.
TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K.
Mod Pathol. 1 Feb 2008; 21(2)186-91.
EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.
Laimer K, Fong D, Gastl G, Obrist P, Kloss F, Tuli T, Gassner R, Rasse M, Norer B, Spizzo G.
Oral Oncol 1 Jan 2008; 44(1)72-7.
Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue.
Spizzo G, Gastl G, Obrist P, Fong D, Haun M, Grunewald K, Parson W, Eichmann C, Millinger S, Fiegl H, Margreiter R, Amberger A.
Cancer Lett. 8 Feb 2007; 246(1-2)253-61. Epub 2006 Apr 18.
High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B.
Oral Oncol. 1 Feb 2007; 43(2)193-8. Epub 2006 Jul 18.
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG.
Gynecol Oncol. 1 Nov 2006; 103(2)483-8. Epub 2006 May 6.